Pharmacy

The FINANCIAL -- Novartis on September 11 announced results from a Phase III study of 870 patients with stage III...

The FINANCIAL -- Bristol-Myers Squibb Company on September 7 announced that it has completed the previously announced planned acquisition of...

The FINANCIAL -- Eli Lilly and Company on September 7 announced actions to streamline operations to more efficiently focus resources on...

The FINANCIAL -- Merck, known as MSD outside the United States and Canada, and Rigontec on September 6 announced that...

The FINANCIAL -- An innovative new methodology for evaluating the benefits of new medicines has been developed by a team...

The FINANCIAL -- Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, has informed the Board of Directors of his desire...

The FINANCIAL -- Amgen on August 31 announced that the European Commission (EC) has granted Marketing Authorization of a pediatric...

The FINANCIAL -- Roche announced on August 30 that the US Food and Drug Administration (FDA) has approved Actemra/RoActemra® (tocilizumab)...

The FINANCIAL -- Novartis announced on August 30 that the US Food and Drug Administration (FDA) has approved Kymriah(TM)(tisagenlecleucel) suspension...

The FINANCIAL -- AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the U.S. and Canada) on August...

The FINANCIAL -- Novo Nordisk A/S on August 15 announced two changes to its Executive Management team.

The FINANCIAL -- Sales within diabetes and obesity care increased by 11% to DKK 47.5 billion (10% in local currencies).

The FINANCIAL -- Teva Pharmaceutical Industries Ltd. announced on August 7 that the U.S. Food and Drug Administration (FDA) has...

The FINANCIAL -- AbbVie on August 3 announced that the U.S. Food and Drug Administration (FDA) approved MAVYRET (glecaprevir/pibrentasvir), a...

The FINANCIAL -- Bristol-Myers Squibb Company and IFM Therapeutics (IFM) announced on August 3 that the companies have signed a...